Is Elicio Therapeutics, Inc. (ELTX) a Buy, Sell, or Hold?
Elicio Therapeutics, Inc.
NASDAQ:ELTX
$3.04 USD
-$0.07 (-2.25%)
- Volume
- 745.32K
- Average Volume
- 1.66M
- Market Capitalization
- $57.96M
- P/E Ratio
- -1.29
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $16.00
- Year Low
- $2.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.24
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
22
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
2
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 3.44M
ELTX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ELTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Connelly Robert | director, officer: CEO, President and Director | 2026-02-02 | A-Award | 8.1 | 2026-02-03 |
| Connelly Robert | director, officer: CEO, President and Director | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Shah Preetam | officer: See Remarks | 2026-02-02 | A-Award | 8.1 | 2026-02-03 |
| Shah Preetam | officer: See Remarks | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| DeMuth Peter | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 8.1 | 2026-02-03 |
| DeMuth Peter | officer: Chief Scientific Officer | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Haqq Christopher | officer: See Remarks | 2026-02-02 | A-Award | 0 | 2026-02-03 |
| Haqq Christopher | officer: See Remarks | 2026-02-02 | A-Award | 8.1 | 2026-02-03 |
| DeMuth Peter | officer: Chief Scientific Officer | 2025-12-09 | M-Exempt | 4.41 | 2025-12-10 |
| DeMuth Peter | officer: Chief Scientific Officer | 2025-12-09 | M-Exempt | 4.41 | 2025-12-10 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2025-06-03 | A-Award | 7.75 | 2025-06-04 |
| Ashe Carol Gail | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| Nissenson Allen | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| Venkatesan Jay | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| ADAMS JULIAN | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| WILSON KAREN J | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| RUFFOLO ROBERT R | director | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2025-05-19 | A-Award | 5.84 | 2025-05-20 |
| Shah Preetam | officer: See Remarks | 2025-04-15 | A-Award | 4.98 | 2025-04-16 |
| Shah Preetam | officer | 2025-03-24 | 0 | 2025-04-02 | |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2025-03-05 | C-Conversion | 5.81 | 2025-03-07 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2025-03-05 | C-Conversion | 5.81 | 2025-03-07 |
| DeMuth Peter | officer: Chief Scientific Officer | 2025-02-03 | A-Award | 8.92 | 2025-02-04 |
| Haqq Christopher | officer: See Remarks | 2025-02-03 | A-Award | 8.92 | 2025-02-04 |
| Connelly Robert | director, officer: CEO, President and Director | 2025-02-03 | A-Award | 8.92 | 2025-02-04 |
| DeMuth Peter | officer: Chief Scientific Officer | 2024-12-16 | M-Exempt | 4.41 | 2024-12-18 |
| DeMuth Peter | officer: Chief Scientific Officer | 2024-12-16 | M-Exempt | 4.41 | 2024-12-18 |
| Venkatesan Jay | director | 2024-11-26 | X-InTheMoney | 0.01 | 2024-11-29 |
| Venkatesan Jay | director | 2024-11-26 | X-InTheMoney | 0.01 | 2024-11-29 |
| WILSON KAREN J | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| ADAMS JULIAN | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| Ashe Carol Gail | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| Venkatesan Jay | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| RUFFOLO ROBERT R | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| Nissenson Allen | director | 2024-11-21 | A-Award | 5.12 | 2024-11-25 |
| Connelly Robert | director, officer: CEO, President and Director | 2024-09-30 | A-Award | 5.03 | 2024-10-02 |
| DeMuth Peter | officer: Chief Scientific Officer | 2024-09-30 | A-Award | 5.03 | 2024-10-02 |
| Haqq Christopher | officer: See Remarks | 2024-09-30 | A-Award | 5.03 | 2024-10-02 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2024-08-12 | P-Purchase | 5.81 | 2024-08-14 |
| Venkatesan Jay | director | 2024-06-28 | P-Purchase | 5 | 2024-07-02 |
| Venkatesan Jay | director | 2024-06-28 | P-Purchase | 0.01 | 2024-07-02 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2024-06-28 | P-Purchase | 5 | 2024-07-02 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2024-06-28 | P-Purchase | 0.01 | 2024-07-02 |
| Chudnovsky Yekaterina | director, 10 percent owner: | 2024-03-19 | P-Purchase | 0.01 | 2024-03-20 |
| Piekos Brian | officer: Chief Financial Officer | 2024-02-01 | A-Award | 4.5 | 2024-02-05 |
| Connelly Robert | director, officer: CEO, President and Director | 2024-02-01 | A-Award | 4.5 | 2024-02-05 |
| Haqq Christopher | officer: See Remarks | 2024-02-01 | A-Award | 4.5 | 2024-02-05 |
| DeMuth Peter | officer: Chief Scientific Officer | 2024-02-01 | A-Award | 4.5 | 2024-02-05 |
| DeMuth Peter | officer: Chief Scientific Officer | 2024-02-01 | A-Award | 4.5 | 2024-02-05 |